chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: positive Covid-19 test result; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (positive Covid-19 test result) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 029L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Apr-2021, the patient experienced SARS-COV-2 TEST POSITIVE (positive Covid-19 test result). At the time of the report, SARS-COV-2 TEST POSITIVE (positive Covid-19 test result) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Apr-2021, SARS-CoV-2 test: (Positive) tested positive for Covid-19.   Action taken with mRNA-1273 in response to the events was not applicable     No concomitant medications provided No treatment medications provided
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation
Clinical narrative: experienced a burning sensation; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (experienced a burning sensation) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BURNING SENSATION (experienced a burning sensation). At the time of the report, BURNING SENSATION (experienced a burning sensation) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications include Equate Saline Spray solution on a daily basis to rinse out her nose. Treatment details were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Follow up received on 16-jun-2021 and the case outcome was updated from unknown to recovered
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Lymphadenopathy, Muscular weakness
Clinical narrative: "hardly lift the hand"; lymph nodes near neack and right arm swelling; left side "spleen" pain; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (left side "spleen" pain), MUSCULAR WEAKNESS ("hardly lift the hand") and LYMPHADENOPATHY (lymph nodes near neack and right arm swelling) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 007M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ABDOMINAL PAIN (left side "spleen" pain). On 16-Mar-2021, the patient experienced MUSCULAR WEAKNESS ("hardly lift the hand") and LYMPHADENOPATHY (lymph nodes near neack and right arm swelling). On 20-Mar-2021, MUSCULAR WEAKNESS ("hardly lift the hand") outcome was unknown. At the time of the report, ABDOMINAL PAIN (left side "spleen" pain) and LYMPHADENOPATHY (lymph nodes near neack and right arm swelling) outcome was unknown.            This case was linked to US-MODERNATX, INC.-MOD-2021-068276 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-068276:
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vision blurred
Clinical narrative: low grade fever; blurred vision, not able to read; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (low grade fever) and VISION BLURRED (blurred vision, not able to read) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031m20a) for COVID-19 vaccination.     The patient's past medical history included Blood pressure abnormal. Concurrent medical conditions included Nasal allergy. Concomitant products included LISINOPRIL for Blood pressure abnormal.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced PYREXIA (low grade fever) and VISION BLURRED (blurred vision, not able to read). In March 2021, PYREXIA (low grade fever) and VISION BLURRED (blurred vision, not able to read) had resolved. Not Provided          The patient's medical history and relevant concomitant medications weren't reported Treatment information was not provided; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-080441:friends case
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Vaccine administered to special population; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine administered to special population) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine administered to special population). On 06-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine administered to special population) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   concomitant medications not provided Treatment information was not provided
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Impaired work ability, Pain, Pyrexia, SARS-CoV-2 test
Clinical narrative: unable to work; body ache and pain today; fever; headache; This spontaneous case was reported by a consumer and describes the occurrence of IMPAIRED WORK ABILITY (unable to work), PAIN (body ache and pain today), PYREXIA (fever) and HEADACHE (headache) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced IMPAIRED WORK ABILITY (unable to work), PAIN (body ache and pain today), PYREXIA (fever) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) on 05-Apr-2021 at an unspecified dose and frequency. At the time of the report, IMPAIRED WORK ABILITY (unable to work), PAIN (body ache and pain today), PYREXIA (fever) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In July 2020, SARS-CoV-2 test: (Positive) COVID-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided   This case was linked to MOD21-070876 (Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 07-Apr-2021: Added lab data and added events; Sender's Comments:  MOD21-070876:
Sex: F
Vaccine: COVID19
Symptoms: Illness, Pyrexia
Clinical narrative: got really sick; Fever; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (got really sick) and PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (got really sick) and PYREXIA (Fever). At the time of the report, ILLNESS (got really sick) and PYREXIA (Fever) outcome was unknown.   Action taken with mRNA-1273 in response to the events was not applicable    No concomitant medications provided Treatment information was not provided   This case was linked to MOD-2021-072952 (Patient Link).
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental overdose
Clinical narrative: Invalid dose of Moderna Vaccine 1ml; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL OVERDOSE (Invalid dose of Moderna Vaccine 1ml) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     Concomitant products included POTASSIUM, TIOTROPIUM BROMIDE (SPIRIVA), WARFARIN SODIUM (COUMADIN), PARACETAMOL (TYLENOL), BENZONATATE (TESSALON PERLE), SALBUTAMOL (ALBUTEROL HFA), AMLODIPINE BESILATE (NORVASC), ATORVASTATIN CALCIUM (LIPITOR), FORMOTEROL FUMARATE, MOMETASONE FUROATE (DULERA), FUROSEMIDE (LASIX [FUROSEMIDE]), METOPROLOL, MIRTAZAPINE (REMERON) and OXYMETAZOLINE (AFRIN [OXYMETAZOLINE]) for an unknown indication.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 ml. On 06-Apr-2021, the patient experienced ACCIDENTAL OVERDOSE (Invalid dose of Moderna Vaccine 1ml). On 06-Apr-2021, ACCIDENTAL OVERDOSE (Invalid dose of Moderna Vaccine 1ml) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD21-071001, MOD21-070955, MOD21-071039, MOD21-071041, MOD21-071043, MOD21-071046, MOD21-071048 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Follow-up received on 26 may 2021. Vaccination facility details updated.; Sender's Comments: This report refers to a case of Accidental Overdose for mRNA-1273 (Lot #: 044A21A)  with no associated AEs. MOD21-071001: MOD21-070955: MOD21-071039: MOD21-071041: MOD21-071043: MOD21-071046: MOD21-071048:
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Feeling hot, Headache, Hyperhidrosis
Clinical narrative: dizziness; perspiration while sleeping; warmness; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), HYPERHIDROSIS (perspiration while sleeping), FEELING HOT (warmness) and HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No relevant medical history provided).   On 02-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced DIZZINESS (dizziness), HYPERHIDROSIS (perspiration while sleeping), FEELING HOT (warmness) and HEADACHE (Headache). At the time of the report, DIZZINESS (dizziness), HYPERHIDROSIS (perspiration while sleeping), FEELING HOT (warmness) and HEADACHE (Headache) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not Applicable.  Concomitant medications were provided.  No treatment information provided
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Myalgia, Peripheral coldness
Clinical narrative: felt his feet were cold; joint pain; muscle pain; headache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL COLDNESS (felt his feet were cold), ARTHRALGIA (joint pain), MYALGIA (muscle pain), HEADACHE (headache) and FATIGUE (fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No relevant medical history provided).   On 06-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced PERIPHERAL COLDNESS (felt his feet were cold), ARTHRALGIA (joint pain), MYALGIA (muscle pain), HEADACHE (headache) and FATIGUE (fatigue). On 07-Apr-2021, PERIPHERAL COLDNESS (felt his feet were cold), ARTHRALGIA (joint pain) and MYALGIA (muscle pain) had resolved. At the time of the report, HEADACHE (headache) and FATIGUE (fatigue) outcome was unknown.            No medical history and concomitant medications were provided.  No treatment information provided
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Extreme fatigue. She was in bed for 2.5 days; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Extreme fatigue. She was in bed for 2.5 days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (Extreme fatigue. She was in bed for 2.5 days). The patient was treated with Bed rest (for 2.5 days) for Fatigue. At the time of the report, FATIGUE (Extreme fatigue. She was in bed for 2.5 days) outcome was unknown. Not Provided
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 16 year old patient recived first dose of Moderna Covid-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old patient recived first dose of Moderna Covid-19 vaccine) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046A21A and 031b21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old patient recived first dose of Moderna Covid-19 vaccine). On 19-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old patient recived first dose of Moderna Covid-19 vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The concomitant medications were not reported. The treatment information was not provided.    Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: The follow up document was received and had significant information. Added patient demographics, batch number updated.; Sender's Comments: This report refers to a case of Product administered to patient of inappropriate age, for mRNA-1273, lot # 046A21A, with no associated AEs.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Diarrhoea
Clinical narrative: diarrhea; was very weak; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) and ASTHENIA (was very weak) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     The patient's past medical history included Stroke, Wheelchair user, Communication disorder NOS and Artificial cardiac pacemaker user. Concurrent medical conditions included Blood pressure abnormal.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced DIARRHOEA (diarrhea) and ASTHENIA (was very weak). At the time of the report, DIARRHOEA (diarrhea) and ASTHENIA (was very weak) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       concomitant medications provided as 13 pills a day (for blood pressure , for everything). Treatment information was not provided
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Rash
Clinical narrative: rash on the  arm; felt really tired; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on the  arm) and FATIGUE (felt really tired) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No relevant medical history provided).    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced FATIGUE (felt really tired). On an unknown date, the patient experienced RASH (rash on the  arm). At the time of the report, RASH (rash on the  arm) and FATIGUE (felt really tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's medical history  and relevant concomitant medications weren't reported Treatment information was not provided
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Arthralgia, Chills, Fatigue
Clinical narrative: lack of smell; lack of taste; tired; chills; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of ANOSMIA (lack of smell), AGEUSIA (lack of taste), ARTHRALGIA (joint pain), FATIGUE (tired) and CHILLS (chills) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     The patient's past medical history included Leukemia. Concurrent medical conditions included Chemotherapy NOS.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced ARTHRALGIA (joint pain). On 06-Apr-2021, the patient experienced ANOSMIA (lack of smell), AGEUSIA (lack of taste), FATIGUE (tired) and CHILLS (chills). At the time of the report, ANOSMIA (lack of smell), AGEUSIA (lack of taste), ARTHRALGIA (joint pain), FATIGUE (tired) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Insomnia, Tonsillar hypertrophy
Clinical narrative: Swelling of tonsils; Sleeping difficulty; Headache; This spontaneous case was reported by a consumer and describes the occurrence of TONSILLAR HYPERTROPHY (Swelling of tonsils), INSOMNIA (Sleeping difficulty) and HEADACHE (Headache) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No relevant medical history provided).    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced TONSILLAR HYPERTROPHY (Swelling of tonsils), INSOMNIA (Sleeping difficulty) and HEADACHE (Headache). At the time of the report, TONSILLAR HYPERTROPHY (Swelling of tonsils), INSOMNIA (Sleeping difficulty) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       She stated that she had reactions to dogs in past that are similar to this symptom.  The patient's medical history and relevant concomitant medications weren't reported Treatment information was not provided
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Lymph node pain, Lymphadenopathy, Mass
Clinical narrative: Injection site redness; Swollen lymph nodes; Lymph node pain; Bumps on the left arm; Injection site itching; large red blotchy patch around injection site, very itchy; This spontaneous case was reported by a consumer and describes the occurrence of MASS (Bumps on the left arm), RASH PRURITIC (large red blotchy patch around injection site, very itchy), INJECTION SITE PRURITUS (Injection site itching), INJECTION SITE ERYTHEMA (Injection site redness) and LYMPHADENOPATHY (Swollen lymph nodes) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Sulfonamide allergy (Allergic to Sulfa), Drug allergy (Allergic to gabapentin), Food allergy (Food allergy to Bananas) and Epilepsy since 30-Jun-2015. Concomitant products included PREGABALIN (LYRICA) for Epilepsy.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced RASH PRURITIC (large red blotchy patch around injection site, very itchy). On 06-Apr-2021, the patient experienced MASS (Bumps on the left arm) and INJECTION SITE PRURITUS (Injection site itching). On 07-Apr-2021, the patient experienced INJECTION SITE ERYTHEMA (Injection site redness), LYMPHADENOPATHY (Swollen lymph nodes) and LYMPH NODE PAIN (Lymph node pain). On 01-Apr-2021, RASH PRURITIC (large red blotchy patch around injection site, very itchy) had resolved. At the time of the report, MASS (Bumps on the left arm), INJECTION SITE PRURITUS (Injection site itching), INJECTION SITE ERYTHEMA (Injection site redness), LYMPHADENOPATHY (Swollen lymph nodes) and LYMPH NODE PAIN (Lymph node pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.   This case was linked to MOD-2021-251800 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: Patient details, medical history, and event details was updated..
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: Injection site redness; Swollen lymph nodes; Lymph node pain; Bumps on the left arm; Injection site itching; large red blotchy patch around injection site, very itchy; This spontaneous case was reported by a consumer and describes the occurrence of MASS (Bumps on the left arm), RASH PRURITIC (large red blotchy patch around injection site, very itchy), INJECTION SITE PRURITUS (Injection site itching), INJECTION SITE ERYTHEMA (Injection site redness) and LYMPHADENOPATHY (Swollen lymph nodes) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Sulfonamide allergy (Allergic to Sulfa), Drug allergy (Allergic to gabapentin), Food allergy (Food allergy to Bananas) and Epilepsy since 30-Jun-2015. Concomitant products included PREGABALIN (LYRICA) for Epilepsy.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced RASH PRURITIC (large red blotchy patch around injection site, very itchy). On 06-Apr-2021, the patient experienced MASS (Bumps on the left arm) and INJECTION SITE PRURITUS (Injection site itching). On 07-Apr-2021, the patient experienced INJECTION SITE ERYTHEMA (Injection site redness), LYMPHADENOPATHY (Swollen lymph nodes) and LYMPH NODE PAIN (Lymph node pain). On 01-Apr-2021, RASH PRURITIC (large red blotchy patch around injection site, very itchy) had resolved. At the time of the report, MASS (Bumps on the left arm), INJECTION SITE PRURITUS (Injection site itching), INJECTION SITE ERYTHEMA (Injection site redness), LYMPHADENOPATHY (Swollen lymph nodes) and LYMPH NODE PAIN (Lymph node pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.   This case was linked to MOD-2021-251800 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: Patient details, medical history, and event details was updated..
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Myalgia; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Myalgia) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    In April 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced MYALGIA (Myalgia). At the time of the report, MYALGIA (Myalgia) outcome was unknown. Not Provided          No concomitant medications were reported. No treatment information was provided by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2021-069810 (Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-069810:
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Antibody test, Antibody test negative
Clinical narrative: he didn't have any antibodies; This spontaneous case was reported by a consumer and describes the occurrence of ANTIBODY TEST NEGATIVE (he didn't have any antibodies) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. unknown and unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced ANTIBODY TEST NEGATIVE (he didn't have any antibodies). At the time of the report, ANTIBODY TEST NEGATIVE (he didn't have any antibodies) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Apr-2021, Antibody test: negative Blood test for antibodies after Covid-19 vaccination negative.         On 1Apr2021, he had a blood test. The antibodies were tested at the time. Blood test showed that he didn't have any antibodies.  Action taken with mRNA-1273 in response to the events was not Applicable.  Concomitant product use was not provided by the reporter. Treatment information was not provided.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Headache, Muscle atrophy, Myalgia, Pain in extremity
Clinical narrative: muscles are dying; arm feels like arm is punched; headache; sore muscle; fever; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE ATROPHY (muscles are dying), PAIN IN EXTREMITY (arm feels like arm is punched), HEADACHE (headache), MYALGIA (sore muscle) and PYREXIA (fever) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.  The patient's past medical history included Head and neck cancer. Concomitant products included LEVOTHYROXINE, CITALOPRAM, LOSARTAN, LOVASTATIN and FAMOTIDINE for an unknown indication.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCLE ATROPHY (muscles are dying), PAIN IN EXTREMITY (arm feels like arm is punched), HEADACHE (headache), MYALGIA (sore muscle) and PYREXIA (fever). At the time of the report, MUSCLE ATROPHY (muscles are dying), PAIN IN EXTREMITY (arm feels like arm is punched), HEADACHE (headache), MYALGIA (sore muscle) and PYREXIA (fever) outcome was unknown.  DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.1 (Inconclusive) 100.1F.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.    No treatment medicine has been reported by reporter.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: muscles are dying; arm feels like arm is punched; headache; sore muscle; fever; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE ATROPHY (muscles are dying), PAIN IN EXTREMITY (arm feels like arm is punched), HEADACHE (headache), MYALGIA (sore muscle) and PYREXIA (fever) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.  The patient's past medical history included Head and neck cancer. Concomitant products included LEVOTHYROXINE, CITALOPRAM, LOSARTAN, LOVASTATIN and FAMOTIDINE for an unknown indication.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCLE ATROPHY (muscles are dying), PAIN IN EXTREMITY (arm feels like arm is punched), HEADACHE (headache), MYALGIA (sore muscle) and PYREXIA (fever). At the time of the report, MUSCLE ATROPHY (muscles are dying), PAIN IN EXTREMITY (arm feels like arm is punched), HEADACHE (headache), MYALGIA (sore muscle) and PYREXIA (fever) outcome was unknown.  DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.1 (Inconclusive) 100.1F.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.    No treatment medicine has been reported by reporter.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Insomnia, Pain, Pyrexia
Clinical narrative: Unable to sleep; fever; Headache; Body pain; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), HEADACHE (Headache), PAIN (Body pain) and INSOMNIA (Unable to sleep) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 06-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 06-Apr-2021, the patient experienced PYREXIA (fever), HEADACHE (Headache) and PAIN (Body pain). On an unknown date, the patient experienced INSOMNIA (Unable to sleep). At the time of the report, PYREXIA (fever), HEADACHE (Headache), PAIN (Body pain) and INSOMNIA (Unable to sleep) outcome was unknown. Not Provided          Concomitant drugs were not provided and Treatment none
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Itchy arm below the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy arm below the injection site) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itchy arm below the injection site). At the time of the report, PRURITUS (Itchy arm below the injection site) outcome was unknown. Possible      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Rash, Urticaria
Clinical narrative: They are tiny red bumps; she developed a rash; It goes across your chest, abdomen, and going down both legs. She said it reminds her of how; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (They are tiny red bumps), RASH (she developed a rash) and RASH (It goes across your chest, abdomen, and going down both legs. She said it reminds her of how) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (She had COVID about 9 months ago and recovered.) and Chickenpox (chicken pox started when she was 18.).    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced URTICARIA (They are tiny red bumps), RASH (she developed a rash) and RASH (It goes across your chest, abdomen, and going down both legs. She said it reminds her of how). At the time of the report, URTICARIA (They are tiny red bumps), RASH (she developed a rash) and RASH (It goes across your chest, abdomen, and going down both legs. She said it reminds her of how) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. The patient had took Benadryl and cortisone cream as a treatment.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia
Clinical narrative: Felt tired; Low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Felt tired) and PYREXIA (Low grade fever) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 031M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 15-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 16-Mar-2021, the patient experienced FATIGUE (Felt tired) and PYREXIA (Low grade fever). At the time of the report, FATIGUE (Felt tired) and PYREXIA (Low grade fever) had not resolved. Not Provided          No Concomitant medication were provided
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site mass, Vaccination site pain, Vaccination site pruritus
Clinical narrative: swollen lump at injection site; itchiness at injection site; he had injection arm pain for two days; v shaped marking that is 4 or 5 inches around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (swollen lump at injection site), VACCINATION SITE PRURITUS (itchiness at injection site), VACCINATION SITE PAIN (he had injection arm pain for two days) and VACCINATION SITE ERYTHEMA (v shaped marking that is 4 or 5 inches around the injection site) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (v shaped marking that is 4 or 5 inches around the injection site). On 31-Mar-2021, the patient experienced VACCINATION SITE PAIN (he had injection arm pain for two days). On 06-Apr-2021, the patient experienced VACCINATION SITE MASS (swollen lump at injection site) and VACCINATION SITE PRURITUS (itchiness at injection site). On 02-Apr-2021, VACCINATION SITE PAIN (he had injection arm pain for two days) had resolved. At the time of the report, VACCINATION SITE MASS (swollen lump at injection site), VACCINATION SITE PRURITUS (itchiness at injection site) and VACCINATION SITE ERYTHEMA (v shaped marking that is 4 or 5 inches around the injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site hypersensitivity, Vaccination site hypoaesthesia, Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: he can still feel where the injection was; very sensitive in one spot where they injected vaccine; area is a tad warm and swollen; tender to the touch; can feel it if he bumps or touches the injected area; high in bicep area where his shoulder and arm is connected in muscle/injection was kind of high in arm muscle; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HYPOAESTHESIA (he can still feel where the injection was), VACCINATION SITE HYPERSENSITIVITY (very sensitive in one spot where they injected vaccine), VACCINATION SITE WARMTH (area is a tad warm and swollen), VACCINATION SITE PAIN (tender to the touch) and VACCINATION SITE SWELLING (can feel it if he bumps or touches the injected area) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced VACCINATION SITE HYPOAESTHESIA (he can still feel where the injection was), VACCINATION SITE HYPERSENSITIVITY (very sensitive in one spot where they injected vaccine), VACCINATION SITE WARMTH (area is a tad warm and swollen), VACCINATION SITE PAIN (tender to the touch), VACCINATION SITE SWELLING (can feel it if he bumps or touches the injected area) and VACCINATION SITE PAIN (high in bicep area where his shoulder and arm is connected in muscle/injection was kind of high in arm muscle). At the time of the report, VACCINATION SITE HYPOAESTHESIA (he can still feel where the injection was), VACCINATION SITE HYPERSENSITIVITY (very sensitive in one spot where they injected vaccine), VACCINATION SITE WARMTH (area is a tad warm and swollen), VACCINATION SITE PAIN (tender to the touch), VACCINATION SITE SWELLING (can feel it if he bumps or touches the injected area) and VACCINATION SITE PAIN (high in bicep area where his shoulder and arm is connected in muscle/injection was kind of high in arm muscle) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Second dose scheduled on 25Apr2021.  Concomitant product use was not provided by the reporter. Treatment information was not provided.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tired) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Tired). At the time of the report, FATIGUE (Tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       CONCOMINANT AND TREATMENT DRUGS WERE NOT USED. LAB DATA WAS NOT GIVEN.
Sex: U
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: Different side effects after vaccination; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Different side effects after vaccination) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Different side effects after vaccination). At the time of the report, ADVERSE EVENT (Different side effects after vaccination) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. The treatment information was unknown.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: diagnosed with COVID; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (diagnosed with COVID) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced COVID-19 (diagnosed with COVID). At the time of the report, COVID-19 (diagnosed with COVID) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Mar-2021, COVID-19: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: Swollen Injection Site (3-4" ); Sore Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swollen Injection Site (3-4" )) and VACCINATION SITE PAIN (Sore Injection Site) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced VACCINATION SITE SWELLING (Swollen Injection Site (3-4" )) and VACCINATION SITE PAIN (Sore Injection Site). At the time of the report, VACCINATION SITE SWELLING (Swollen Injection Site (3-4" )) and VACCINATION SITE PAIN (Sore Injection Site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Vaccination complication
Clinical narrative: Had a similar reaction with the Moderna covid vaccine as she did with the flu vaccine; Allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Had a similar reaction with the Moderna covid vaccine as she did with the flu vaccine) and HYPERSENSITIVITY (Allergic reaction) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced HYPERSENSITIVITY (Allergic reaction). On an unknown date, the patient experienced VACCINATION COMPLICATION (Had a similar reaction with the Moderna covid vaccine as she did with the flu vaccine). At the time of the report, VACCINATION COMPLICATION (Had a similar reaction with the Moderna covid vaccine as she did with the flu vaccine) and HYPERSENSITIVITY (Allergic reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  The patient took Benadryl as treatment medication for the events.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling
Clinical narrative: arm is sore; arm is swollen; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm is sore) and PERIPHERAL SWELLING (arm is swollen) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced PAIN IN EXTREMITY (arm is sore) and PERIPHERAL SWELLING (arm is swollen). At the time of the report, PAIN IN EXTREMITY (arm is sore) and PERIPHERAL SWELLING (arm is swollen) outcome was unknown.            There is no information about any medications like concomitant or treatment.   Reporter did not allow further contact
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Pyrexia, Rash
Clinical narrative: Rash on forehead and private region; Fever radiating from rash; Rash is sensitive to pressure; Loss of sleep due to discomfort; Fever; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on forehead and private region), PYREXIA (Fever radiating from rash), RASH (Rash is sensitive to pressure), INSOMNIA (Loss of sleep due to discomfort) and PYREXIA (Fever) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced PYREXIA (Fever). On 06-Apr-2021, the patient experienced RASH (Rash on forehead and private region), PYREXIA (Fever radiating from rash), RASH (Rash is sensitive to pressure) and INSOMNIA (Loss of sleep due to discomfort). On 01-Apr-2021, PYREXIA (Fever) had resolved. At the time of the report, RASH (Rash on forehead and private region), PYREXIA (Fever radiating from rash), RASH (Rash is sensitive to pressure) and INSOMNIA (Loss of sleep due to discomfort) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.